Molecular Matrix, Inc. articles

Mesenchymal stem cells (MSC) differentiate towards multiple lineages that participate in bone formation and are often utilized for bone regeneration therapy. A 2019 review by Lee et al. explores the endogenous mechanical and biochemical environment of MSCs. Additionally, the article highlights the essential factors that lead to bone repair and how these factors can be leveraged to improve bone regeneration therapy.

Osteogenesis, or new bone formation, begins in the early stages of embryonic development and continues postnatally until skeletal maturity is reached in early adulthood. Osteogenesis reoccurs in the event of bone trauma, such as a fracture or surgically created defect. Bone mass can also increase in response to chronic weight bearing from daily use or decrease due to a lack of movement or applied force, further illustrating the dynamic nature of bone tissue. A closer look at the b

Prolotherapy has been a part of modern orthopedic practices since the 1940s. It is growing in popularity not just in the U.S., but globally as well. Also known as “regenerative injection therapy” (RIT), prolotherapy is a procedure used to treat musculoskeletal conditions including tendinopathies, osteoarthritis, and chronic pain of the cervical spine, lumbar spine, and pelvis (Sit et al. 2017). The procedure involves the administration of a therapeutic solution injecte